• Publications
  • Influence
WED 170 The utility of brain FDG-PET in a patient with natalizumab associated PML-IRIS
Natalizumab, a highly effective disease modifying drug used in relapsing remitting multiple sclerosis (RRMS), is associated with progressive multifocal leukoencephalopathy (PML), a fatalExpand